You are here: Skip Navigation LinksDepartment of Dermatology, Venerology and Allergology

Workgroup PD Dr. rer. nat. habil. Anja Saalbach

​​

​Dr. Anja Saalbach's research group is working on the elucidation of mechanisms that regulate inflammatory and tissue repair processes in the skin. The focus is on the following topics​.

Thy-1 – an anti-fibrotic factor?

​Thymocyte differentiation antigen 1 (Thy-1, CD90) is expressed on fibroblasts, neurons, activated microvascular endothelial cells, glomerular cells, a subpopulation of hematopoietic stem cells, mesenchymal stem cells, and T cells (only in mice). Thy-1 regulates many core functions of fibroblasts that are relevant to fibrogenesis, such as matrix protein deposition, proliferation, apoptosis, cytokine and growth factor expression and responsiveness, cell adhesion, migration, and myofibroblast differentiation.

Broad portfolio of methods and reagents

In our laboratory, we have investigated the function of Thy-1 on microvascular endothelial cells, fibroblasts, and mesenchymal stem cells. We have established a broad portfolio of methods and reagents that enable these investigations. These include various Thy-1 knockout mouse models, Thy-1 overexpressing cell lines, self-generated antibodies against Thy-1, and ELISA assays for the detection of murine and human soluble Thy-1. We are currently investigating the role of neuronal Thy-1.

Research findings

Our data show that Thy-1 is essential for maintaining tissue homeostasis. Elucidating the underlying signaling pathways is another key focus of our research.​

​Publications

  • Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Immunol. 2004;172:3850–9.
  • Thy-1 (CD90) regulates the extravasation of leukocytes during inflammation. Eur J Immunol. 2011;41:645–56.
  • Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium. Oncogene. 2005;24:4710–20.
  • Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact  of Thy-1. J Invest Dermatol. 2015;135:1893–902.
  • Thy-1/beta3 Integrin Interaction-Induced Apoptosis of Dermal Fibroblasts Is Mediated by Up-Regulation of FasL Expression. J Invest Dermatol. 2016;136:526–9.
  • Thy-1 (CD90) promotes bone formation and protects against obesity. Sci Transl Med [Internet]. 2018;10:eaao6806. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30089635
  • Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis. Arthritis Care Res. 2013; 65: 281–7.
  • Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease. Liver Int [Internet]. 2024; 44: 2075–90. Available at: https://onlinelibrary.wiley.com/doi/10.1111/liv.15956
  • Antifibrotic Soluble Thy-1 Correlates with Renal Dysfunction in Chronic Kidney Disease. Int J Mol Sci [Internet]. 2023; 24: 1896. Available at: https://www.mdpi.com/1422-0067/24/3/1896

Role of Dermal Adipose Tissue

Role of Dermal Adipose Tissue in the Regulation of Inflammatory Responses

Recent research indicates that white skin-associated adipose tissue (dWAT) performs a variety of functions beyond its traditional role as an energy reservoir. In contrast to other fat depots, there is limited data on the immunoregulatory functions of this specific fat depot. One of our main research focuses is the role of dWAT in controlling inflammatory processes in the skin.

Previous results

We have recently shown that skin inflammation triggers the activation of dWAT. Soluble mediators released from activated dWAT, in turn, stimulate the expression of numerous genes in inflammatory cells that regulate skin inflammation. Among these are the Th2 cytokines interleukin-4 (IL-4) and interleukin-13 (IL-13). IL-4 and IL-13 initiate the resolution of inflammatory responses and stimulate tissue repair processes. Interleukin-33 (IL-33), which is released from activated dWAT, is responsible for this IL-4/13 stimulation in myeloid cells.

Disturbance of the signal cascade

Interestingly, obesity impairs IL-33 secretion from dWAT during inflammation, leading to reduced IL-4 and IL-13 expression in myeloid cells.

Our data reveal an IL-33–IL-4/13 signaling cascade initiated by dWAT in a Th2-independent inflammatory context, which may help to limit inflammation. This cascade appears to be disrupted in obese individuals with persistent inflammation.​



Dermal white adipose tissue derived IL-33 regulates interleukin 4/13 expression in myeloid cells during inflammation. J Invest Dermatol. 2025 Feb;145(2):370-382​​

Connection Between Obesity and Inflammation

Obesity has increased dramatically over the past decades. In addition to its detrimental effects on metabolism and the cardiovascular system, obesity also disrupts immune and inflammatory responses, promoting inflammatory and autoimmune processes. For instance, obesity exacerbates the severity of many inflammatory diseases, such as psoriasis—a chronic inflammatory skin disorder. These facts highlight the magnitude of the challenge and the need to understand the relationship between obesity and inflammation.


In our laboratory, we investigate the connection between obesity and inflammatory skin diseases such as psoriasis. Recently, using mouse models and in vitro approaches, we demonstrated that saturated fatty acids and the protein S100A9 are key factors contributing to obesity-related enhancement of skin inflammation. These findings are now being translated into clinical studies.​

​Mechanisms of Obesity-Induced Exacerbation of Inflammatory Responses in the Skin

A) Obesity or a high-fat diet leads to an increase in saturated fatty acids (SFA), which under homeostatic conditions have no effect on the skin.

B) The release of S100A9 during injury/inflammation, in the absence of elevated SFAs, does not promote activation of macrophages/monocytes.

C) During injury or inflammation, S100A9 is released. The binding of S100A9 to TLR4 and subsequent activation of NF-κB induces the gene expression of IL-1β in macrophages. In the presence of elevated SFAs—such as occurs with obesity or a high-fat diet—the inflammasome in these cells is activated, leading to the release of IL-1β. IL-1β released by macrophages in turn enhances the expression of S100A9 in the epidermis and in dermal white adipose tissue (dWAT), thereby triggering a sustained S100A9 response during skin inflammation. Additionally, S100A9 impairs macrophage activation and polarization, thus preventing the resolution of skin inflammation. This ultimately contributes to chronic and intensified skin inflammation and impaired tissue repair.

(From: Franz S, Ertel A, Engel KM, Simon JC, Saalbach A. Theranostics. 2022; 12: 1659–82.)​

​Publications

  • Modulation of Dietary Fatty Acids in an Open-Label Study Improves Psoriasis and Dampens the Inflammatory Activation Status. Nutrients. 2023;
  • Overexpression of S100A9 in obesity impairs macrophage differentiation via  TLR4-NFkB-signaling worsening inflammation and wound healing. Theranostics. 2022; 12: 1659–82.
  • Psoriasis: Obesity and Fatty Acids. Front Immunol. 2019; 10: 1807.
  • High-Fat Diet Exacerbates Early Psoriatic Skin Inflammation Independent of Obesity: Saturated Fatty Acids as Key Players. J Invest Dermatol. 2018; 138: 1999–2009.​
Philipp-Rosenthal-Str., Haus 10
04103 Leipzig
Phone:
0341 - 97 18666
Fax:
0341 - 97 18609
Map